Abbott Laboratories
ABT: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|#C | LOCK|>fdj | LOCK|f$sn^K |
Abbott Earnings: Pockets of Strength More Than Offset Areas of Softness
Abbott's third-quarter results included reported revenue growth of 7%, with US nutrition sales falling 7% and global device revenue up 15% year over year.
